Study identification

PURI

https://redirect.ema.europa.eu/resource/1000000505

EU PAS number

EUPAS1000000505

Study ID

1000000505

Official title and acronym

PASS TachoSil Evaluation (PasTel): Short- and long-term safety evaluation of TachoSil in paediatric population

DARWIN EU® study

No

Study countries

Poland

Study status

Planned

Contact details

Piotr Kalicinski

Primary lead investigator
Study timelines

Date when funding contract was signed

Actual:

Study start date

Planned:

Date of final study report

Planned:
Sources of funding
Pharmaceutical company and other private sector 
Regulatory

Was the study required by a regulatory body?

Yes

Is the study required by a Risk Management Plan (RMP)?

EU RMP category 3 (required)